authors
- Bagai, Akshay
- Bhatt, Deepak L
- Eikelboom, John
- Mancini, GB John
- Cohen, Eric A
- Vijayaraghavan, Ram
- Cheema, Asim N
- Udell, Jacob A
- Niznick, Joel
- Tanguay, Jean-Francois
- Verma, Subodh
- Mehta, Shamir
Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 24, 2016
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Acute Coronary Syndrome (MeSH)
- Aged (MeSH)
- Aged, 80 and over (MeSH)
- Aspirin (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Administration Schedule (MeSH)
- Female (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Percutaneous Coronary Intervention (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Precision Medicine (MeSH)
- Purinergic P2Y Receptor Antagonists (MeSH)
- Ticlopidine (MeSH)
published in
- Circulation Journal